CDK 8/19 Kinase Inhibitor RVU120 in Patients with AML or Higher-Risk MDS: Safety and Efficacy Results from New Dose Escalation Cohorts

Camille Abboud; Jan Maciej Zaucha; Scott R. Solomon; Terrence Bradley; Elie Mouhayar; Noemi Angelosanto; Hendrik Nogai; Renata Dudziak; Tomasz Rzymski; Peter Littlewood; Krzysztof Brzózka; Axel Glasmacher; Gautam Borthakur; Howard A. Burris; Ewa Lech Marańda

doi:10.1182/blood-2022-163150

Back

CDK 8/19 Kinase Inhibitor RVU120 in Patients with AML or Higher-Risk MDS: Safety and Efficacy Results from New Dose Escalation Cohorts

Journal article

Open access

Peer reviewed

CDK 8/19 Kinase Inhibitor RVU120 in Patients with AML or Higher-Risk MDS: Safety and Efficacy Results from New Dose Escalation Cohorts

Camille Abboud, Jan Maciej Zaucha, Scott R. Solomon, Terrence Bradley, Elie Mouhayar, Noemi Angelosanto, Hendrik Nogai, Renata Dudziak, Tomasz Rzymski, Peter Littlewood, …

Blood, Vol.140(Supplement 1), pp.6228-6229

2022-11-15

DOI: https://doi.org/10.1182/blood-2022-163150

Appears in Miller School of Medicine - Latest Publications

Files and links (1)

url

https://doi.org/10.1182/blood-2022-163150View

Published (Version of record) Open

Metrics

7 Record Views

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: CDK 8/19 Kinase Inhibitor RVU120 in Patients with AML or Higher-Risk MDS: Safety and Efficacy Results from New Dose Escalation Cohorts
Creators: Camille Abboud - Washington University in St. Louis
Jan Maciej Zaucha - University Clinical Centre
Scott R. Solomon - Northside Hospital
Terrence Bradley - Sylvester Comprehensive Cancer Center
Elie Mouhayar - 5MDACC, Houston, TX
Noemi Angelosanto - 6Ryvu Therapeutics, Cracow, Poland
Hendrik Nogai - 6Ryvu Therapeutics, Cracow, Poland
Renata Dudziak - 7Ryvu Therapeutics, Kraków, Poland
Tomasz Rzymski - 6Ryvu Therapeutics, Cracow, Poland
Peter Littlewood - 8Ryvu Therapeutics, Krakow, Poland
Krzysztof Brzózka - 6Ryvu Therapeutics, Cracow, Poland
Axel Glasmacher - University Hospital Bonn
Gautam Borthakur - The University of Texas MD Anderson Cancer Center
Howard A. Burris - Sarah Cannon
Ewa Lech Marańda - Institute of Hematology and Transfusion Medicine, Warsaw, Poland
Publication Details: Blood, Vol.140(Supplement 1), pp.6228-6229
Publisher: Elsevier Inc
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031786605702976